Literature DB >> 103559

Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus.

N Zein, C Ganuza, I Kushner.   

Abstract

Serum C-reactive protein (CRP) concentration was determined by a radial immunodiffusion method in serum samples collected over a mean period of 19 months from a group of 17 patients with systemic lupus erythematosus (SLE). Thirty-two episodes of CRP elevation were detected. Twenty of these were associated with active SLE, and 9 with proven or possible infection or bone fracture. In 3 cases no explanation for CRP elevation was readily apparent. There were 8 instances of onset or exacerbation of lupus activity without accompanying CRP elevation. These data indicate that CRP elevation in the course of SLE is frequently associated with activation of lupus, and that detection of such elevation does not differentiate between lupus activity and infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 103559     DOI: 10.1002/art.1780220102

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

Review 1.  The use of laboratory tests in the diagnosis of SLE.

Authors:  W Egner
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

2.  Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis.

Authors:  T Inoue; T Takeda; S Koda; N Negoro; M Okamura; K Amatsu; M Kohno; T Horiguchi; Y Kanayama
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

3.  Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients.

Authors:  Emad Abdallah; Samya El-Shishtawy; Nevine Sherif; Ahmed Ali; Omnia El-Bendary
Journal:  Int Urol Nephrol       Date:  2016-11-23       Impact factor: 2.370

4.  Studies on autoantibodies to poly (adenosine diphosphate-ribose) in SLE and other autoimmune diseases.

Authors:  W J Morrow; D A Isenberg; H F Parry; L Shen; E E Okolie; F Farzaneh; S Shall; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

5.  DNA antibodies and complement in SLE patients. A follow-up study.

Authors:  T Helve; P Kurki; A M Teppo; O Wegelius
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

6.  C-reactive protein and serological indices of disease activity in systemic lupus erythematosus.

Authors:  J V Bertouch; P J Roberts-Thompson; P H Feng; J Bradley
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

7.  Serum C-reactive protein measurement in the detection of intercurrent infection in Oriental patients with systemic lupus erythematosus.

Authors:  C R Hind; S C Ng; P H Feng; M B Pepys
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

8.  Serum beta 2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus.

Authors:  C P Maury; T Helve; C Sjöblom
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

9.  C-reactive protein in childhood dermatomyositis.

Authors:  R H Haas; R F Dyck; V Dubowitz; M B Pepys
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

10.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage.

Authors:  Ana M Bertoli; Luis M Vilá; John D Reveille; Graciela S Alarcón
Journal:  J Rheumatol       Date:  2008-11-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.